← All trials
NCT05158673
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2022
- Primary completion
- Dec 31, 2022
- Completion date
- Jul 1, 2023
- First posted
- Dec 15, 2021
- Last posted
- Dec 15, 2021
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesLead sponsor
- Instituto Politécnico NacionalStudy director
- Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesReponsible party - principal investigator
- National Polytechnic Institute, MexicoCollaborator
- Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.